Binax

Binax is a prominent medical diagnostics company specializing in the development and manufacture of rapid, point-of-care testing solutions for infectious diseases. Best known for its BinaxNOW lateral flow technology, the company provides quick and reliable results for conditions such as COVID-19, influenza, malaria, and Legionnaires' disease. Originally founded in 1986 and based in Portland, Maine, Binax was acquired by Inverness Medical Innovations (later Alere) in 2005, which was subsequently acquired by Abbott Laboratories in 2017. The company's products are widely utilized in clinics, hospitals, and home settings globally to facilitate rapid clinical decision-making without the need for specialized laboratory equipment. During the COVID-19 pandemic, Binax became a household name due to the massive scale-up and distribution of its rapid antigen self-tests.